ArticleInternational journal of molecular sciences2022

Targeting TLR2/Rac1/cdc42/JNK Pathway to Reveal That Ruxolitinib Promotes Thrombocytopoiesis.

Shuo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.